
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Hepatobiliary Diseases
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1510679
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: The SAF (Steatosis, Activity, Fibrosis) score, a histological scoring system proposed by the European Group for the Study of Fatty Liver, is used to evaluate liver biopsy samples in non-alcoholic fatty liver disease (NAFLD). Based on pathological results and SAF scores, NAFLD patients were categorized into mild, moderate, and severe groups. We compared the differences among these groups and identified risk factors influencing lesion severity.Method: We selected data from 539 NAFLD patients who underwent percutaneous liver biopsy confirmation at the Beijing Ditan Hospital from January 2018 to December 2022. All biopsies were graded according to the SAF scoring system, and the severity of the disease was classified as mild, moderate, and severe. The differences in gender, age, BMI, history of diabetes, history of hypertension, AST, ALT, serum cholesterol level and other aspects of patients with NAFLD of different severity were compared, and the risk factors affecting the severity of their lesions were further explored.Result: A total of 539 patients were enrolled in this study, aged from 6 to 79 years old, including 325 males and 214 females with an average age of 39 ± 13 years. They were divided into mild NAFLD group (162 cases), moderate NAFLD group (210 cases), and severe NAFLD group (167 cases). The results showed significant differences among the three groups in terms of age composition, high calorie diet, family history of hypertension, ALT, AST, GGT, total bile acids, cholinesterase, glycosylated albumin, blood glucose, uric acid, type III procollagen, serum human laminin, liver hardness, and hepatic steatosis.Conclusion: BMI, uric acid, AST, type III procollagen, liver hardness, and liver steatosis indicators play important roles in the progression of NAFLD and are risk factors for high pathological SAF scores in NAFLD patients.
Keywords: Non-alcoholic fatty liver disease, SAF score, steatosis and fibrosis, Risk factors, NAFLD (non alcoholic fatty liver disease)
Received: 13 Oct 2024; Accepted: 12 Mar 2025.
Copyright: © 2025 Li, Wang, Zhang, Deng, Zhang, Cao, Wei, Gao, Yao, Wang, Xie, Yi and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yao Xie, Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University. Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China
Hui Ming Li, Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University. Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.